Ignite Creation Date:
2025-12-25 @ 3:07 AM
Ignite Modification Date:
2025-12-26 @ 1:46 AM
Study NCT ID:
NCT00833833
Status:
COMPLETED
Last Update Posted:
2016-04-27
First Post:
2009-01-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma
Sponsor:
Celgene Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-06
Start Date Type:
None
Primary Completion Date:
2011-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-09
Completion Date Type:
ACTUAL
First Submit Date:
2009-01-30
First Submit QC Date:
None
Study First Post Date:
2009-02-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-03-08
Results First Submit QC Date:
None
Results First Post Date:
2013-04-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-03-25
Last Update Post Date:
2016-04-27
Last Update Post Date Type:
ESTIMATED